Annemarie M. Van Nieuwenhuijze
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A robust pipeline with high replication rate for detection of somatic variants in the adaptive immune system as a source of common genetic variation in autoimmune disease.
Journal: Human molecular genetics
Published: November 09, 2018
Mice Deficient in Nucleoporin Nup210 Develop Peripheral T Cell Alterations.
Journal: Frontiers in immunology
Published: March 31, 2018
CCR7 Modulates the Generation of Thymic Regulatory T Cells by Altering the Composition of the Thymic Dendritic Cell Compartment.
Journal: Cell reports
Published: August 12, 2016
Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice.
Journal: Cellular and molecular life sciences : CMLS
Published: June 21, 2016
Inflammatory Gene Expression Profile and Defective Interferon-γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 08, 2016
The Molecular Control of Regulatory T Cell Induction.
Journal: Progress in molecular biology and translational science
Published: November 29, 2015
Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: February 05, 2015
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: January 16, 2014
The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: April 27, 2013
GM-CSF as a therapeutic target in inflammatory diseases.
Journal: Molecular immunology
Published: March 14, 2013
Bcl-2 overexpression ameliorates immune complex-mediated arthritis by altering FcγRIIb expression and monocyte homeostasis.
Journal: Journal of leukocyte biology
Published: January 24, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026